2021
DOI: 10.1007/s12070-021-02561-5
|View full text |Cite
|
Sign up to set email alerts
|

Endonasal Endoscopic Dacryocystorhinostomy with and Without Stents–A Comparative Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 27 publications
0
3
0
1
Order By: Relevance
“…This is contradictory to the study done by Nitin et al where most of the cases presented with the disease on the left side accounting for 72% of the total cases and 28% had disease on the right side. 18 We evaluated 50 patients, of which 25 patients underwent endonasal DCR with a stent, and 25 patients without a stent. The stent was removed 1 month post surgery.…”
Section: Discussionmentioning
confidence: 99%
“…This is contradictory to the study done by Nitin et al where most of the cases presented with the disease on the left side accounting for 72% of the total cases and 28% had disease on the right side. 18 We evaluated 50 patients, of which 25 patients underwent endonasal DCR with a stent, and 25 patients without a stent. The stent was removed 1 month post surgery.…”
Section: Discussionmentioning
confidence: 99%
“…Similar to the treatment of choanal atresia, the use of silicone stents, both in external and endoscopic DCR, is controversial. In some centers, their use is systematic; in others, they are targeted and used only when canal stenosis is suspected or during revision surgery [38]. The goal is to ensure permanent patency of the DCR ostium.…”
Section: Therapymentioning
confidence: 99%
“…Ähnlich wie bei der Therapie der Choanalatresien wird der Einsatz von Silikonstents, sowohl bei der externen als auch bei der endoskopischen DCR, kontrovers diskutiert. In einigen Zentren erfolgt der Einsatz systematisch, in anderen gezielt und nur bei Verdacht auf eine Kanalstenose oder bei Revisionsoperationen [38]. Ziel ist es, die dauerhafte Durchgängigkeit des DCR-Ostiums zu gewährleisten.…”
Section: Prognoseunclassified
“…Surgical failures primarily stem from scarring and the healing and sealing of the osteotomy site due to cicatrization [2][3] . The use of antifibrotic agents such as mitomycin C can potentially improve success rates by preventing cicatrix formation and scarring through their wound-modifying effects [4][5][6][7] . A Meta-analysis on mitomycin C's efficacy in both external and endoscopic DCR has confirmed its safety and effectiveness in reducing osteotomy closure rates [5][6] .…”
Section: Introductionmentioning
confidence: 99%